As Amazon’s purchase of PillPack shook up the pharmaceutical industry this week, Bloomberg turned to Ernie Cecilia, Chief Investment Officer at Bryn Mawr Trust, for comment. Ernie underscored the often-disruptive nature of Amazon’s rumored and actual intrusions to business models.
To read the article, you may access Bloomberg’s website here.
